Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of WELCURE DRUG. For more details, see the WELCURE DRUG quarterly results and WELCURE DRUG share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 13.51 |
1 Week | % | 10.2 |
1 Month | % | 25.2 |
1 Year | % | 18.2 |
52 week H/L | Rs | 5.5/3.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
WELCURE DRUG EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1 | 1 | 2 | 12 | 12 | |
Low | Rs | 1 | NA | NA | 2 | 4 | |
Sales per share (Unadj.) | Rs | 0.1 | 0.1 | 0.1 | 0.1 | 0 | |
Earnings per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.1 | |
Diluted earnings per share | Rs | 0.0 | -0.0 | 0.0 | 0.0 | 0.1 | |
Cash flow per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 0 | 0 | 0.1 | 0.1 | 1.1 | |
Adj. book value per share | Rs | 0.0 | 0.0 | 0.1 | 0.1 | 1.1 | |
Shares outstanding (eoy) | m | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | |
Price / Sales ratio | x | 16.1 | 8.1 | 13.5 | 89.8 | 0 | |
Avg P/E ratio | x | 320.9 | -70.4 | 32.5 | 401.1 | 100.7 | |
P/CF ratio (eoy) | x | 320.9 | -70.4 | 32.5 | 401.1 | 97.5 | |
Price / Book Value ratio | x | 54.1 | 46.9 | 25.9 | 101.3 | 6.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 13 | 7 | 18 | 94 | 102 | |
Total wages/salary | Rs m | 0 | 0 | 0 | 0 | 0 |
WELCURE DRUG INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1 | 1 | 1 | 1 | 0 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 2 | |
Total revenues | Rs m | 1 | 1 | 1 | 1 | 2 | |
Gross profit | Rs m | 0 | 0 | 1 | 0 | -1 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 0 | 0 | 1 | 0 | 1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 0 | 0 | 1 | 0 | 1 | |
Gross profit margin | % | 2.9 | -11.6 | 41.4 | 22.5 | 0 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | 4.9 | -11.3 | 41.5 | 22.5 | 0 |
WELCURE DRUG BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 0 | 0 | 1 | 1 | 0 | |
Current liabilities | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net working cap to sales | % | 29.6 | 17.2 | 52.2 | 59.2 | 0 | |
Current ratio | x | 5.0 | 2.5 | 18.3 | 16.5 | 0.4 | |
Inventory Days | Days | 0 | 0 | 0 | 107 | 0 | |
Debtors Days | Days | 0 | 0 | 0 | 0 | 0 | |
Net fixed assets | Rs m | 0 | 0 | 0 | 0 | 15 | |
Share capital | Rs m | 121 | 121 | 121 | 121 | 134 | |
"Free" reserves | Rs m | -121 | -121 | -120 | -120 | -119 | |
Net worth | Rs m | 0 | 0 | 1 | 1 | 15 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 0 | 0 | 1 | 1 | 15 | |
Interest coverage | x | 0 | 0 | 0 | 0 | 0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.7 | 3.3 | 1.8 | 1.1 | 0 | |
Return on assets | % | 13.2 | -37.2 | 75.7 | 24.4 | 6.7 | |
Return on equity | % | 16.2 | -67.1 | 79.9 | 25.4 | 6.7 | |
Return on capital | % | 16.5 | -66.4 | 80.1 | 25.4 | 6.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
WELCURE DRUG CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 0 | -0 | 0 | 0 | 1 | |
From Investments | Rs m | 0 | 0 | 0 | 0 | 13 | |
From Financial Activity | Rs m | 0 | 0 | 0 | 0 | -15 | |
Net Cashflow | Rs m | 0 | -0 | 0 | 0 | -1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Altaf Hussain Shah | COMP SEC: Manowar Ali | YEAR OF INC: 1996 | BSE CODE: 524661 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare WELCURE DRUG With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.